ArticleCureus2024
Non-Surgical Management of Gallstones During Pregnancy: A Clinical Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Investigation of Adverse Events Associated with Predicted GnRHR Agonists Using the FAERS Database.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gallstone disease during pregnancy, or cholelithiasis, presents significant clinical challenges due to hormonal, anatomical, and metabolic changes. Progesterone therapy, commonly used in pregnancy for uterine bleeding, can exacerbate gallstone risk by reducing gallbladder motility and promoting cholesterol gallstone formation. This case report describes a 29-year-old pregnant woman with no prior gallbladder disease who developed multiple cholesterol gallstones during the third trimester while undergoing progesterone therapy for bleeding associated with a bicornuate uterus. Conservative management during pregnancy, including dietary modifications and close monitoring, was successful, and the patient delivered a healthy infant via cesarean section. Postpartum, the patient developed obstructive jaundice, severe right hypochondriac pain, and scleral icterus due to common bile duct obstruction from gallstones. Endoscopic retrograde cholangiopancreatography (ERCP) with biliary stent placement resolved the obstruction, and pharmacological treatment with ursodeoxycholic acid (UDCA) and omega-3 fatty acids led to complete gallstone resolution within three months. Surgical intervention was avoided to prioritize postpartum recovery and breastfeeding, which resumed successfully after a brief interruption. This case highlights the value of individualized, multidisciplinary care in managing pregnancy-associated gallstone disease. Conservative approaches, including pharmacological and minimally invasive interventions, can achieve effective outcomes while minimizing maternal-fetal risks. Routine ultrasound screening in high-risk pregnancies and further investigation into UDCA and omega-3 therapies, progesterone-related gallbladder stasis, and postpartum biliary stenting protocols are recommended to optimize management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.